Royalty Payments; Reports. Within [***] ([***]) days after the end of each calendar quarter for which royalties are due by Ono to Merus, Ono shall pay Merus all such amounts payable by it under Section 6.4 by wire transfer on a country by country basis. Each such payment shall be accompanied with a report, providing in reasonable detail an accounting of all Net Sales made during such calendar quarter and the calculation of any royalties due under Section 6.4.
Royalty Payments; Reports. (a) Upon execution of this Agreement, and upon renewal of this Agreement as set forth in Paragraph 3 above, Licensee shall pay to University an annual licensing fee of one hundred dollars ($100). Within thirty (30) days of the end of the Initial Term and, if applicable, each respective Renewal Period, Licensee shall provide University with a written report of number of Licensed Articles sold and pay to University any additional fees due based on Licensee’s annual gross sales as set out in Appendix C and incorporated herein. In the event that Licensee’s annual gross sales for the Initial Term or Renewal Period, as applicable, exceed $5,000, Licensee shall pay University a royalty of sixteen percent (16%) of the Gross Sales in excess of $5,000.
(b) Royalty Reports must be completed and submitted to The University of Utah within 30 days of license renewal or termination. PENALTY: a fee of $25 will be charged if royalty report is not submitted to The University of Utah within 30 days.
Royalty Payments; Reports. Tanabe shall, (i) for a period equaling the longer of ten (10) years from the date of the initial sale of each Product for each indication in the Territory or the expiration of the last Signal Patent, Joint Patent or Tanabe Patent (including in each case patents deemed to exist as a result of a Use or Structure Contribution by Tanabe, Signal or both Parties) which claims the use or sale of such Product in the country of sales, pay to Signal a royalty in U.S. dollars equal to the percentages ("Royalty Rates") set forth in Exhibit D and (ii) for so long as sales of any Product gives rise to an obligation by Signal to pay patent royalties to a Third Party, reimburse Signal for any and all such Third-Party patent royalties ("Third-Party Royalties"), subject to Section 5.4(e) below, due by Signal pursuant to its license ("Reimbursements"). Thereafter, [***] Tanabe shall remain liable for all royalties payable by its Affiliates or sublicensees.
Royalty Payments; Reports. (a) Within forty-five (45) days after the end of each quarter of Licensee's Fiscal Year, Licensee shall:
(i) Deliver to Licensor a report, certified by its chief financial officer, giving the following particulars concerning Net Revenues and corresponding Royalties that accrued during the preceding quarter of Licensee's Fiscal Year, together with [*]
(A) Net Revenues derived from sale of Sporting Goods and Services other than for which Licensee is required to pay a revenue share, impressions fee, cost-per-click fee, or other promotional or advertising fee;
(B) Net Revenues derived from sale of Sporting Goods and Services for which Licensee is required to pay a revenue share, impressions fee, cost-per-click fee, or other promotional or advertising fee;
(C) Net Revenues derived from the sale of Sporting Goods and Services to Customers who access the XXX.xxx Site from kiosks in TSA Stores, and the Operating Profit from such Kiosk sales;
(D) Net Revenues of the TSA Site derived from all other sources;
(E) Amount of Royalties due to Licensor with respect to the TSA Site itemized with respect to items (A) through (D) above; and
(F) Amount of tax of any kind properly withheld and/or paid to tax authorities by Licensee.
(ii) Pay: (A) the Royalties to TSAMI; and (B) all other payments due hereunder to TSA. Payments made in respect of the fourth quarter of each of Licensee's Fiscal Years shall be subject to subsequent adjustment, as necessary, to reflect the results of the independent auditor's report required by subsection (c) below. Subject to the limitations set forth in Section 11.3(b), receipt or acceptance of any report or payment shall not preclude Licensor from questioning the correctness thereof at any time. In the event that any inconsistency or mistake is discovered by either Licensor or Licensee in such reports, it shall be promptly rectified and, within fifteen (15) Business Days, the appropriate report shall be delivered by the Party with the duty to report.
Royalty Payments; Reports. Royalties under Section 8.4 shall be calculated and reported for each Calendar Quarter during the Royalty Term and shall be paid within thirty (30) Business Day after the end of the applicable Calendar Quarter, commencing with the Calendar Quarter in which the First Commercial Sale of a Product occurs. Each payment of royalties shall be accompanied by a report of Net Sales of the Products by Advaccine, its Affiliates and their respective Sublicensees in sufficient detail to permit confirmation of the accuracy of the royalty payment made, including: (a) the amount of gross sales and Net Sales of the Products in the Advaccine Territory on a Product-by-Product and Region-by-Region basis, (b) an itemized calculation showing the deductions from gross sales (by major category as set forth in the definition of Net Sales) to determine Net Sales, and (c) a calculation of the amount of royalties due to Inovio in U.S. Dollars, including the application of any exchange rate used.
Royalty Payments; Reports. (a) Within [*] days after the end of each [*] of Licensee's Fiscal Year, Licensee shall:
(i) Deliver to Licensor a report, certified by its chief financial officer, giving the following particulars [*]: [*]
(ii) Pay: (A) the Royalties to TSAMI; and (B) all other payments due hereunder to TSA. Payments made in respect of the fourth quarter of each of Licensee's Fiscal Years shall be subject to subsequent adjustment, as necessary, to reflect the results of the independent auditor's report required by subsection (c) below. Subject to the limitations set forth in Section 11.3(b), receipt or acceptance of any report or payment shall not preclude Licensor from questioning the correctness thereof at any time. In the event that any inconsistency or mistake is discovered by either Licensor or Licensee in such reports, it shall be promptly rectified and, within fifteen (15) Business Days, the appropriate report shall be delivered by the Party with the duty to report.
Royalty Payments; Reports. Beginning with the calendar quarter in which the first commercial sale of the first Royalty Product in the Territory has taken place, royalty payments and reports of the sale of the applicable product(s) for each calendar quarter will be calculated and delivered to Ilypsa under this Restated Agreement within forty-five (45) days of the end of such calendar quarter. Each royalty payment shall be accompanied by a report of Net Sales setting forth (a) Net Sales on a Royalty Product-by-Royalty Product and country-by-country basis during the applicable calendar quarter; and (b) a calculation of the royalty payment due hereunder for such calendar quarter for each Royalty Product.
Royalty Payments; Reports. Payments of royalties to SEQUENOM under Article 5.2 based upon Net Revenues will be made on a monthly basis and within thirty (30) days of the close of each calendar month. With each monthly payment, SPECIALTY shall provide SEQUENOM with a written report setting forth sufficient information to verify Net Revenues received by SPECIALTY.
Royalty Payments; Reports. Payments of royalties to SEQUENOM under Article ------------------------ 5.2 based upon Net Revenues will be made on a monthly basis and within thirty (30) days of the close of each calendar month. With each monthly payment, SPECIALTY shall provide SEQUENOM with a written report setting forth sufficient information to verify Net Revenues received by SPECIALTY.
Royalty Payments; Reports. Royalties will be paid by Genzyme on Net Sales of Product in the Genzyme Territory no later than forty-five (45) days after the end of each calendar quarter in which such Net Sales are made. Such payments will be accompanied by a report setting out the details necessary to calculate the amounts actually due hereunder with respect to Net Sales of Product made in that calendar quarter, including gross sales of Product in the calendar quarter sold on a country-by-country basis, all relevant deductions, and all relevant exchange rate conversions. If no earned royalties are due for a calendar quarter after Marketing Approval in the Genzyme Territory, Genzyme will so report. Genzyme will require each Affiliate and sublicensee to make appropriate reports to Genzyme in a timely manner to enable Genzyme to comply with this Section 6.6.4. If Net Sales in one or more territories in the Genzyme Territory are unavailable or cannot be calculated during the 45 day period, then **** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission Genzyme may use an estimate of Net Sales and Net Sales Adjustments in such territory or territories based on the Net Sales in the applicable territory during the previous calendar quarter. Each subsequent quarterly report shall reconcile any estimates included in a previous report.
